The Peptide Blockade

Premium

Scientists have used molecular engineering techniques and a follow-up cell-based assay to block HIV entry into cells. In their work, published in August in the Proceedings of the National Academy of Sciences, they took advantage of the fact that engineered peptides can stably interact with cell surface proteins to block HIV infection of cells. In the future, the technique could be used as an alternative to current therapies that rely on antibody-based drugs, says lead author Sam Gellman, a chemist at the University of Wisconsin, Madison.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.